Valneva SE Operating Income 2021-2025 | VALN

Valneva SE operating income from 2021 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Valneva SE Operating Income 2021-2025 | VALN

Valneva SE operating income from 2021 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$220.2B
Boston Scientific (BSX)$157B
Stryker (SYK)$154B
EssilorLuxottica (ESLOY)$136.6B
Medtronic (MDT)$119.2B
Lonza Group Ag (LZAGY)$50.3B
Haleon (HLN)$44.4B
ResMed (RMD)$40.3B
GE HealthCare Technologies (GEHC)$35.5B
Agilent Technologies (A)$34.1B
Terumo (TRUMY)$25.8B
Koninklijke Philips (PHG)$25.2B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$19.3B
Baxter (BAX)$15B
Smith & Nephew SNATS (SNN)$13.9B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.9B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B